Picture of Global Cord Blood logo

CORBF Global Cord Blood Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall Cap

Momentum

Relative Strength (%)
1m+15.17%
3m+13.5%
6m+12.62%
1yr-57.68%
Volume Change (%)
10d/3m-88.04%
Price vs... (%)
52w High-50%
50d MA+2.98%
200d MA+2.19%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital7.72%
Return on Equity10.82%
Operating Margin48.97%

Financial Summary

Year End 31st MarUnit201820192020202120222023E2024ECAGR / Avg
Total RevenueCNYm936.77986.751,221.461,159.641,243.26n/an/a10.34%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+22.79+20.67+61.52+7.97-1.41n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202331st Mar 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Global Cord Blood EPS forecast chart

Profile Summary

Global Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.

Directors

Last Annual
March 31st, 2022
Last Interim
March 31st, 2022
Incorporated
April 10th, 2006
Public Since
November 19th, 2009
No. of Employees
1,202
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
133,914,711

CORBF Share Price Performance

Upcoming Events for CORBF

Similar to CORBF

Picture of 4Cable TV International logo

4Cable TV International

us flag iconPink Sheets on Nasdaq

Picture of Abattis Bioceuticals logo

Abattis Bioceuticals

us flag iconPink Sheets on Nasdaq

Picture of Accelera Innovations logo

Accelera Innovations

us flag iconPink Sheets on Nasdaq

Picture of ACI Global logo

ACI Global

us flag iconPink Sheets on Nasdaq

Picture of Quantum Medical Transport logo

Quantum Medical Transport

us flag iconPink Sheets on Nasdaq

FAQ